课题基金 / 基金详情

Leukocyte Activating Fc Receptors in Immune Lung Injury

Leukocyte Activating Fc Receptors in Immune Lung Injury
免疫性肺损伤中的白细胞激活 Fc 受体
批准号:
6442716
负责人:
Alan D Schreiber
金额:
$36.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2005-07-31

项目摘要

项目成果

Alan D Schreiber的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Leukocytes such as polymorphonuclear leukocytes (PMN) and macrophages, play an important role both in immune complex disease and in host defense. Macrophages and PMN express on their surface Fcgamma receptors (FcgammaR) which 1) interact with IgG containing immune complexes to produce tissue damage, but 2) also function to clear IgG coated bacteria in host defense. In the lung, Fc receptors and, importantly, the individual Fc receptors have been little studied. We will employ transgenic mice and mice deficient in specific FcR in a combined in vitro and in vivo molecular and cell biology approach to elucidate the role of individual Fc receptors in an animal model of immune lung injury. Both human and mouse macrophages express the activating FcgammaRs FcgammaRI and FcgammaRIIIA which interact with a FcR gamma subunit. We have determined that FcgammaRI is unique among FcR not only in the ability to bind monomeric IgG, but also to signal through both its alpha and gamma subunits. Human macrophages and PMN also express the potent activating FcR FcgammaRIIA, which is absent in mice and does not interact with the y chain. We now have available FcgammaRIIA transgenic (TG) mice, which we have determined express FcgammaRIIA on the macrophage surface to a similar extent as humans and have enhanced clearance of IgG coated cells. Our novel mouse strains include: 1) mice individually lacking either FcgammaRI, FcgammaRIIIA or the gamma chain and 2) mice TG for human FcgammaRIIA (as well as FcgammaRIIA crosses) developed with the participation of our laboratory. Our hypothesis, suggested by our data, is that in the lung FcgammaRI plays a predominant role in the release of inflammatory mediators, while FcgammaRIIA plays a predominant role in host defense. Elucidating the role(s) of specific leukocyte FcgammaRs in the lung is potentially important for developing strategies for effective therapy. Another goal is to define the molecular mechanisms involved in specific mediator release induced by individual lung macrophage FcR, specifically FcgammaRI. We have determined that the cytoplasmic domain (CY) of the FcgammaRI alpha chain is required for release of macrophage IL-6. We will examine structure/function relationships of FcgammaRI involved in signaling for IL-6 release. Human FcgammaRI and chimeras of human FcgammaRI, containing transmembrane domains which cannot associate with endogenous murine Fcgamma receptors, will be transfected into a murine macrophage cell line. Our hypothesis is that specific sequences in the FcgammaRI alpha chain CY, but not the gamma chain, are required for IL-6 release.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biology of the Human Platelet Fc(gamma) Receptor
  • 批准号:
    6741160
  • 项目类别:
  • 资助金额:
    $32.33万
  • 财政年份:
    2003
  • 负责人:
    Alan D Schreiber
  • 依托单位:
BIOLOGY OF HUMAN PLATELET FC(GAMMA) RECEPTORS
  • 批准号:
    6573409
  • 项目类别:
  • 资助金额:
    $19.72万
  • 财政年份:
    2002
  • 负责人:
    Alan D Schreiber
  • 依托单位:
Leukocyte Activating Fc Receptors in Immune Lung Injury
  • 批准号:
    6528176
  • 项目类别:
  • 资助金额:
    $35.53万
  • 财政年份:
    2001
  • 负责人:
    Alan D Schreiber
  • 依托单位:
BIOLOGY OF HUMAN PLATELET FC(GAMMA) RECEPTORS
  • 批准号:
    6435892
  • 项目类别:
  • 资助金额:
    $19.72万
  • 财政年份:
    2001
  • 负责人:
    Alan D Schreiber
  • 依托单位:
海外基金